Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
5.92 CHF
54.78 M CHF
103.41 M CHF
9.32 M
About SANTHERA N
Sector
CEO
Dario Eklund
Headquarters
Pratteln
Website
Founded
1998
ISIN
CH1276028821
FIGI
BBG000QPCJ73
Santhera Pharmaceuticals Holding AG engages in the development and commercialization of products for the treatment of neuromuscular and pulmonary diseases. Its product pipeline includes Vamorolone and Lonodelestat. The company was founded by Thomas Meier in 1998 and is headquartered in Pratteln, Switzerland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SANN is 11.44 CHF — it has increased by 9.37% in the past 24 hours. Watch SANTHERA N stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange SANTHERA N stocks are traded under the ticker SANN.
SANN stock has risen by 16.02% compared to the previous week, the month change is a 48.96% rise, over the last year SANTHERA N has showed a 13.27% increase.
We've gathered analysts' opinions on SANTHERA N future price: according to them, SANN price has a max estimate of 25.00 CHF and a min estimate of 20.00 CHF. Watch SANN chart and read a more detailed SANTHERA N stock forecast: see what analysts think of SANTHERA N and suggest that you do with its stocks.
SANN reached its all-time high on Sep 21, 2015 with the price of 1,389.00 CHF, and its all-time low was 5.00 CHF and was reached on Dec 2, 2022. View more price dynamics on SANN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SANN stock is 10.50% volatile and has beta coefficient of −0.27. Track SANTHERA N stock price on the chart and check out the list of the most volatile stocks — is SANTHERA N there?
Today SANTHERA N has the market capitalization of 138.49 M, it has increased by 8.39% over the last week.
Yes, you can track SANTHERA N financials in yearly and quarterly reports right on TradingView.
SANTHERA N is going to release the next earnings report on Apr 24, 2025. Keep track of upcoming events with our Earnings Calendar.
SANTHERA N revenue for the last half-year amounts to 14.10 M CHF, despite the estimated figure of 5.60 M CHF. In the next half-year revenue is expected to reach 13.70 M CHF.
SANN net income for the last half-year is −15.26 M CHF, while the previous report showed 78.12 M CHF of net income which accounts for −119.54% change. Track more SANTHERA N financial stats to get the full picture.
No, SANN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 44.00 employees. See our rating of the largest employees — is SANTHERA N on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SANTHERA N EBITDA is 57.08 M CHF, and current EBITDA margin is 51.81%. See more stats in SANTHERA N financial statements.
Like other stocks, SANN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SANTHERA N stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SANTHERA N technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SANTHERA N stock shows the neutral signal. See more of SANTHERA N technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.